Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Mahadevan

Showing results (111-120 of 173) with videos related to

Pageof 18
Sort By:
The American Journal of Gastroenterology|October 5, 2023
Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO RegistryRishika Chugh, Millie D Long, Yue Jiang, et al.
Clinical and Translational Gastroenterology|April 6, 2018
Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infantsMichael G Kattah, Jeffrey M Milush, Trevor Burt, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 15, 2011
Cytokine profiles in peripheral blood of children and adults with Crohn diseaseSeung Pak, Nina Holland, Elizabeth A Garnett, et al.
Mbio|August 18, 2016
Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis PatientsJordan S Mar, Brandon J LaMere, Din L Lin, et al.
Clinical and Translational Gastroenterology|August 2, 2018
Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infantsMichael G Kattah, Jeffrey M Milush, Trevor Burt, et al.
Alimentary Pharmacology & Therapeutics|May 13, 2022
Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety databaseUma Mahadevan, Saule Naureckas, Ilia Tikhonov, et al.
Science Translational Medicine|December 3, 2010
IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patientMara J Broadhurst, Jacqueline M Leung, Vikram Kashyap, et al.
Diseases of the Colon and Rectum|May 5, 2016
A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot StudyJessica N Cohan, Elissa M Ozanne, Justin L Sewell, et al.
The Patient|November 9, 2021
Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During PregnancyTatyana Kushner, Angelyn Fairchild, F Reed Johnson, et al.
Inflammatory Bowel Diseases|August 1, 2008
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot studyKelvin T Thia, Uma Mahadevan, Brian G Feagan, et al.
Pageof 18

Showing results (111-120 of 173) with videos related to

Sort By:
Pageof 18
The American Journal of Gastroenterology|October 5, 2023
Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO RegistryRishika Chugh, Millie D Long, Yue Jiang, et al.
Clinical and Translational Gastroenterology|April 6, 2018
Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infantsMichael G Kattah, Jeffrey M Milush, Trevor Burt, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 15, 2011
Cytokine profiles in peripheral blood of children and adults with Crohn diseaseSeung Pak, Nina Holland, Elizabeth A Garnett, et al.
Mbio|August 18, 2016
Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis PatientsJordan S Mar, Brandon J LaMere, Din L Lin, et al.
Clinical and Translational Gastroenterology|August 2, 2018
Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infantsMichael G Kattah, Jeffrey M Milush, Trevor Burt, et al.
Alimentary Pharmacology & Therapeutics|May 13, 2022
Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety databaseUma Mahadevan, Saule Naureckas, Ilia Tikhonov, et al.
Science Translational Medicine|December 3, 2010
IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patientMara J Broadhurst, Jacqueline M Leung, Vikram Kashyap, et al.
Diseases of the Colon and Rectum|May 5, 2016
A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot StudyJessica N Cohan, Elissa M Ozanne, Justin L Sewell, et al.
The Patient|November 9, 2021
Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During PregnancyTatyana Kushner, Angelyn Fairchild, F Reed Johnson, et al.
Inflammatory Bowel Diseases|August 1, 2008
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot studyKelvin T Thia, Uma Mahadevan, Brian G Feagan, et al.
Pageof 18